Pimary Objective
To determine if vitamin D replacement in vitamin D insufficient patients with early stage chronic lymphocytic leukemia (CLL) being managed with observation can improve the percentage of patients requiring treatment with conventional therapy at 36 months to that of a control population of vitamin D sufficient patients.
Secondary
To assess if vitamin D replacement will increase the tumor response rate in Vitamin D insufficient patients.
For Rai Stage 0 and 1 CLL, untreated, SLL Stage 1
clinicaltrials.gov/ct2/show...
Finally this question will be answered with science...rather than speculation and wild claims.